
|Articles|April 15, 2014
- Melanoma (Issue 2)
- Volume 2
- Issue 1
New and Emerging Therapies for Metastatic Melanoma
Author(s)Ryan J. Sullivan, MD
Ryan J. Sullivan, MD, medical oncologist, Massachusetts General Hospital, gives an overview of new and emerging therapies for the treatment of metastatic melanoma.
Advertisement
Ryan J. Sullivan, MD, medical oncologist, Massachusetts General Hospital, gives an overview of new and emerging therapies for the treatment of metastatic melanoma.
Read more about the treatment of metastatic melanoma > >
Articles in this issue
over 11 years ago
Sequencing Strategies in Treating Patients With Melanomaover 11 years ago
Research Into Newer Agents Under Way for NRAS Melanomaover 11 years ago
New Crop of Combination Strategies Growing for Melanomaover 11 years ago
An Overview of Immune Checkpoint Blockadeover 11 years ago
In Practice: Combination Therapies in Metastatic Melanomaover 11 years ago
Mutation Tests in Melanoma Crucial for Treatmentover 11 years ago
What’s Next With Next-Generation BRAF Inhibitors?Advertisement
Advertisement
Advertisement
Trending on Targeted Oncology - Immunotherapy, Biomarkers, and Cancer Pathways
1
FDA Approves T-DXd Plus Pertuzumab for HER2-Positive Breast Cancer
2
Teclistamab/Daratumumab Earns FDA Priority Voucher for R/R Myeloma
3
Roxadustat Granted Orphan Drug Designation for Myelodysplastic Syndromes
4
Gut Health & Myeloma: How Bacteria May Predict Transplant Success With Pooja Phull, MD
5









































